ViiV goes for gold: US premium pricing may threaten dolutegravir use in EuropeAugust 21, 2013
What Can We Look Forward to in HIV Cure Research? Conversation With Research Advocate Richard JefferysAugust 29, 2013
The Affordable Care Act: The name alone is enough to make the eyes of clinicians and patients alike glaze over. Yet the impact of the ACA (colloquially called Obamacare) has the potential to be massive when it comes to access to clinical care for HIV-infected people in the U.S. And with more ACA-related changes on the near horizon, the importance of staying informed has never been greater, particularly for health care providers who work in settings supported by Ryan White CARE Act funding.
To discuss the real-world effects of the ACA and offer guidance to HIV health care professionals, we spoke by phone with two leading experts: Michael Saag, M.D., a professor of medicine and the director of the Center for AIDS Research
at the University of Alabama at Birmingham, as well as a former chair of the HIV Medicine Association
; and Michael Wong, M.D., an associate professor of medicine at Harvard Medical School and the board chairman of HealthHIV
, an education and advocacy organization for frontline care providers.